Merck Enters into Licensing and Collaboration Agreement With
Idera II-78
Sanofi-Aventis Inks a Global Licensing Deal with Oxford
BioMedica II-79
WEHI to Collaborate with Genentech and Roche II-79
AstraZeneca Acquires MedImmune II-79
Antisoma Enters into a Global Accord with Novartis II-79
Sanofi-Aventis and Astellas Pharma to Restructure their JV
Operations in Japan II-79
Biomira Amends its Agreements with Merck II-80
AstraZeneca Takes Over Canadian Biologics Plant II-80
Pfizer to Acquire Coley Pharmaceutical Group II-80
Abraxis Takes Over Watson's Manufacturing Facility II-80
Abraxis Takes Over Pfizer's Cruce Davila Manufacturing Facility II-81
Bristol-Myers Squibb to Take Over Adnexus Therapeutics II-81
Merck to Partner with a Florida-based Research Center II-81
Organon to Partner with Medarex II-81
Genzyme to Acquire Bioenvision II-82
Genentech Inks a Deal with Seattle Genetics II-82
TopoTarget Takes Over Apoxis II-82
Roche to Acquire CuraGen's Subsidiary II-82
GPC Biotech Inks an Agreement with Yakult II-82
MediGene Acquires Avidex II-82
Sanofi-Aventis Inks an Agreement with Taiho II-83
Biogen Inks Merger Agreement with Conforma II-83
Roche Signs a Merger Agreement with Ventana II-83
Roche Takes Over THP to Enhance Its Therapeutic Antibody Profile II-84
ImClone Systems and Merck Revise ERBITUX Agreement II-84
GSK Invests euros 500 Million in France II-84
Amgen Takes Over Avidia II-84
Moores Cancer Center Collaborates with Medarex II-84
ADITUS Medical Forms an Alliance with IGEA II-85
Callisto Opens Site For Phase-II Clinical Trials of Atiprimod II-85
XOMA Inks an Agreement with Attenuon II-85
AstraZeneca Joins Schering to Develop a Novel Breast
'/>"/>
| SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved |